UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

AXL confers cell migration and invasion by hijacking a PEAK1-regulated focal adhesion protein network

Nature communications, 2020-07, Vol.11 (1), p.3586-3586, Article 3586

2020

Volltextzugriff (PDF)

AXL Receptor Tyrosine Kinase as a Promising Therapeutic Target Directing Multiple Aspects of Cancer Progression and Metastasis

Cancers, 2022-01, Vol.14 (3), p.466

2022

Volltextzugriff (PDF)

The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression

Cell reports (Cambridge), 2018-05, Vol.23 (5), p.1476-1490

2018

Volltextzugriff (PDF)

A convolutional neural network STIFMap reveals associations between stromal stiffness and EMT in breast cancer

Nature communications, 2023-06, Vol.14 (1), p.3561-3561, Article 3561

2023

Volltextzugriff (PDF)

HER2 heterogeneity and treatment response-associated profiles in HER2-positive breast cancer in the NCT02326974 clinical trial

The Journal of clinical investigation, 2024-04, Vol.134 (7), p.1-17

2024

Volltextzugriff (PDF)

The E3 Ubiquitin Ligase HectD1 Suppresses EMT and Metastasis by Targeting the +TIP ACF7 for Degradation

Cell reports (Cambridge), 2018-01, Vol.22 (4), p.1016-1030

2018

Volltextzugriff (PDF)

CdGAP is a talin-binding protein and a target of TGF-β signaling that promotes HER2-positive breast cancer growth and metastasis

Cell reports (Cambridge), 2023-08, Vol.42 (8), p.112936-112936, Article 112936

2023

Volltextzugriff (PDF)

CdGAP promotes prostate cancer metastasis by regulating epithelial-to-mesenchymal transition, cell cycle progression, and apoptosis

Communications biology, 2021-09, Vol.4 (1), p.1042-1042, Article 1042

2021

Volltextzugriff (PDF)

Targeting Axl favors an antitumorigenic microenvironment that enhances immunotherapy responses by decreasing Hif-1α levels

Proceedings of the National Academy of Sciences - PNAS, 2021-07, Vol.118 (29), p.1

2021

Volltextzugriff (PDF)

Clinical and translational relevance of intratumor heterogeneity

Trends in cancer, 2023-09, Vol.9 (9), p.726-737

2023

Volltextzugriff (PDF)

Cancer-stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies

Proceedings of the National Academy of Sciences - PNAS, 2024-05, Vol.121 (20), p.e2322688121

2024

Volltextzugriff (PDF)

AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple-negative breast cancer

Oncotarget, 2019-03, Vol.10 (21), p.2055-2067

2019

Volltextzugriff (PDF)

Nck2 Deficiency in Mice Results in Increased Adiposity Associated With Adipocyte Hypertrophy and Enhanced Adipogenesis

Diabetes (New York, N.Y.), 2016-09, Vol.65 (9), p.2652-2666

2016

Volltextzugriff (PDF)

The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression

Cell reports (Cambridge), 2023-12, Vol.42 (12), p.113604-113604, Article 113604

2023

Volltextzugriff (PDF)

Widening of the genetic and clinical spectrum of Lamb–Shaffer syndrome, a neurodevelopmental disorder due to SOX5 haploinsufficiency

Genetics in medicine, 2020-03, Vol.22 (3), p.524-537

2020

Volltextzugriff (PDF)

ITSN1: a novel candidate gene involved in autosomal dominant neurodevelopmental disorder spectrum

European journal of human genetics : EJHG, 2022-01, Vol.30 (1), p.111-116

2022

Volltextzugriff (PDF)

Biallelic ELMO3 mutations and loss of function for DOCK-mediated RAC1 activation result in intellectual disability

Small GTPases, 2022, Vol.13 (1), p.48-55

2022

Volltextzugriff (PDF)

NSCLC metastasis: going with ELMO3

Oncotarget, 2014-08, Vol.5 (15), p.5850-5851

2014

Volltextzugriff (PDF)

Hyperviscosity of the blood and epidural hematoma

Regional anesthesia and pain medicine, 2010-07, Vol.35 (4), p.406-406

2010

Volltextzugriff (PDF)

Abstract LT021: Targeting AXL favors an anti-tumorigenic tumor microenvironment that enhances immunotherapy responses by decreasing HIF-1a levels in cancer cells

Cancer research (Chicago, Ill.), 2021-03, Vol.81 (5_Supplement), p.LT021-LT021

2021

Volltextzugriff (PDF)

Hyperviscosity of the blood and epidural hematoma

Regional anesthesia and pain medicine, 2010, Vol.35 (4), p.406-406

2010

Volltextzugriff (PDF)

Pixelated Microfluidics for Drug Screening on Tumour Spheroids and Ex Vivo Microdissected Tumour Explants

Cancers, 2023-02, Vol.15 (4), p.1060

2023

Volltextzugriff (PDF)

Analyse de la validité des règlements municipaux sur les bandes riveraines

Revue de droit (Sherbrooke), 2008, Vol.39 (1-2), p.261-328

2008

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(22)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

AXL confers cell migration and invasion by hijacking a PEAK1-regulated focal adhesion protein network

AXL Receptor Tyrosine Kinase as a Promising Therapeutic Target Directing Multiple Aspects of Cancer Progression and Metastasis

The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression

A convolutional neural network STIFMap reveals associations between stromal stiffness and EMT in breast cancer

HER2 heterogeneity and treatment response-associated profiles in HER2-positive breast cancer in the NCT02326974 clinical trial

The E3 Ubiquitin Ligase HectD1 Suppresses EMT and Metastasis by Targeting the +TIP ACF7 for Degradation

CdGAP is a talin-binding protein and a target of TGF-β signaling that promotes HER2-positive breast cancer growth and metastasis

CdGAP promotes prostate cancer metastasis by regulating epithelial-to-mesenchymal transition, cell cycle progression, and apoptosis

Targeting Axl favors an antitumorigenic microenvironment that enhances immunotherapy responses by decreasing Hif-1α levels

Clinical and translational relevance of intratumor heterogeneity

Cancer-stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies

AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple-negative breast cancer

Nck2 Deficiency in Mice Results in Increased Adiposity Associated With Adipocyte Hypertrophy and Enhanced Adipogenesis

The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression

Widening of the genetic and clinical spectrum of Lamb–Shaffer syndrome, a neurodevelopmental disorder due to SOX5 haploinsufficiency

ITSN1: a novel candidate gene involved in autosomal dominant neurodevelopmental disorder spectrum

Biallelic ELMO3 mutations and loss of function for DOCK-mediated RAC1 activation result in intellectual disability

NSCLC metastasis: going with ELMO3

Hyperviscosity of the blood and epidural hematoma

Abstract LT021: Targeting AXL favors an anti-tumorigenic tumor microenvironment that enhances immunotherapy responses by decreasing HIF-1a levels in cancer cells

Hyperviscosity of the blood and epidural hematoma

Pixelated Microfluidics for Drug Screening on Tumour Spheroids and Ex Vivo Microdissected Tumour Explants

Analyse de la validité des règlements municipaux sur les bandes riveraines

Suchergebnisse filtern